[1]
Drewes, P,
Thijssen, I,
Mengel, H. A single-dose, crossover pharmacokinetic study comparing racemic citalopramm (40 mg) with the Senantiomer of citalopram (escitalopram, 20 mg) in healthy male volunteers. Poster presented at the Annual Meeting of the New Clinical Data Evaluation Unit (NCDEU), Phoenix (AZ) USA.
2001;29 May-1 June.
Google Scholar